Packer, Douglas L <br/><br/>
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.  [electronic resource] 

 -  Circulation  Dec 2009 
 - 2170-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/CIRCULATIONAHA.109.853689  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amiodarone--therapeutic use<br/>Anti-Arrhythmia Agents--therapeutic use<br/>Cause of Death<br/>Combined Modality Therapy<br/>Death, Sudden, Cardiac--epidemiology<br/>Defibrillators, Implantable<br/>Follow-Up Studies<br/>Heart Failure--drug therapy<br/>Humans<br/>Kaplan-Meier Estimate<br/>Placebos<br/>Proportional Hazards Models<br/>Risk Factors<br/>Tachycardia--drug therapy